U.S. Army Medical Materiel Development Activity (USAMMDA) logo
U.S. Army Medical Materiel Development Activity

Advanced Tissue Biofabrication Manufacturing Innovation - Funding Opportunity Announcement

News release:

U.S. Army Medical Materiel Development Activity Public Affairs Office
1430 Veterans Drive
Fort Detrick, MD 21702-5000

Point of Contact:
USAMMDA Public Affairs
Email: usarmy.detrick.medcom-usammda.mbx.usammda-pao@mail.mil

For Immediate Release -- June 16, 2016

Fort Detrick, Md. - The Department of Defense released a $160 million funding announcement for "Advanced Tissue Biofabrication Manufacturing Innovation Institute". The goal is to advance and develop critical manufacturing and testing technologies for human tissue-based products.

The technical focus of the ATB-MII at a minimum will be comprised of four thrust areas:

Thrust Area 1: Cell & Material Selection & Sourcing
Thrust Area 2: Biofabrication Platforms
Thrust Area 3: Process Design and Automation
Thrust Area 4: Tissue Finishing and Testing Technologies

The ATB-MII will be managed by the U.S. Army Medical Materiel Development Activity and funded by the Office of the Secretary of Defense.

USAMMDA encourages proposals that specifically address advance state-of-the-art tissue manufacturing innovations in cell and biomaterial processing, bioprinting, automation and non-destructive testing technologies.

To view the full funding opportunity announcement: https://www.fbo.gov/index?s=opportunity&mode=form&id=7e026d43e154dd354e5a8e8e91bb7933&tab=core&_cview=1 or search "W911NF-16-R-0021" on FedBizOpps.com or Grants.gov

Additional information can be found at www.Manufacturing.gov and www.Proposersday.org

Last Modified Date: 05/24/2017